Risultati della ricerca - Gil Redelman‐Sidi

  • Mostra 1 - 13 risultati su 13
Raffina i risultati
  1. 1
    Could BCG be used to protect against COVID-19?

    Could BCG be used to protect against COVID-19? di Gil Redelman‐Sidi

    Pubblicazione 2020
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    BCG in Bladder Cancer Immunotherapy

    BCG in Bladder Cancer Immunotherapy di Song Jiang, Gil Redelman‐Sidi

    Pubblicazione 2022
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    Rapidly Growing Mycobacteria Infection in Patients with Cancer

    Rapidly Growing Mycobacteria Infection in Patients with Cancer di Gil Redelman‐Sidi, Kent A. Sepkowitz

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy

    Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy di Tommaso Morelli, Kohei Fujita, Gil Redelman‐Sidi, Paul Elkington

    Pubblicazione 2021
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  5. 5
    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells

    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells di Gil Redelman‐Sidi, Gopa Iyer, David B. Solit, Michael S. Glickman

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathways

    Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathways di Richa Gupta, Daniel Barkan, Gil Redelman‐Sidi, Stewart Shuman, Michael S. Glickman

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling

    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling di Anthony C. Antonelli, Anna Binyamin, Tobias M. Hohl, Michael S. Glickman, Gil Redelman‐Sidi

    Pubblicazione 2020
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune ch... di Gil Redelman‐Sidi, Olivier Michielin, Carlos Cervera, Camillo Ribi, José María Aguado, Mario Fernández‐Ruiz, Oriol Manuel

    Pubblicazione 2018
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  9. 9
    Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer

    Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer di Tilly Varughese, Ying Taur, Nina Cohen, M. Lia Palomba, Susan K. Seo, Tobias M. Hohl, Gil Redelman‐Sidi

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma

    The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma di María del Carmen López Castillo, Fabián Andrés Rosas Romero, Esther Argüello, Chrisann Kyi, Michael A. Postow, Gil Redelman‐Sidi

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    The Canonical Wnt Pathway Drives Macropinocytosis in Cancer

    The Canonical Wnt Pathway Drives Macropinocytosis in Cancer di Gil Redelman‐Sidi, Anna Binyamin, Isabella Gaeta, Wilhelm Palm, Craig B. Thompson, Paul B. Romesser, Scott W. Lowe, Mukta Bagul, John G. Doench, David E. Root, Michael S. Glickman

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Determinants of Severity in Cancer Patients with COVID-19 Illness

    Determinants of Severity in Cancer Patients with COVID-19 Illness di Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, C. Ortiz, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj

    Pubblicazione 2020
    Testo
    Pré-impressão
    Aggiungi alla lista
    Salvato in:
  13. 13
    Determinants of COVID-19 disease severity in patients with cancer

    Determinants of COVID-19 disease severity in patients with cancer di Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, Cesar J. Figueroa, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj

    Pubblicazione 2020
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: